Mercer Global Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16M Sell
17,624
-1,503
-8% -$494K 0.01% 748
2025
Q4
$6.69M Sell
19,127
-3,109
-14% -$1.05M 0.01% 615
2025
Q3
$7.18M Sell
22,236
-14,019
-39% -$4.36M 0.01% 549
2025
Q2
$14.1M Sell
36,255
-20,191
-36% -$8.12M 0.03% 322
2025
Q1
$24.6M Buy
56,446
+10,246
+22% +$4.11M 0.06% 190
2024
Q4
$17M Buy
+46,200
New +$19.3M 0.04% 243
2024
Q1
Sell
-47,038
Closed -$22.2M 2056
2023
Q4
$22.2M Buy
47,038
+5,255
+13% +$2.43M 0.07% 180
2023
Q3
$18.2M Buy
41,783
+571
+1% +$259K 0.07% 175
2023
Q2
$18.3M Buy
41,212
+172
+0.4% +$79.3K 0.07% 183
2023
Q1
$18.9M Buy
41,040
+924
+2% +$440K 0.09% 170
2022
Q4
$20.6M Buy
40,116
+8,656
+28% +$4.4M 0.1% 159
2022
Q3
$14.3M Buy
31,460
+903
+3% +$432K 0.08% 180
2022
Q2
$14.7M Buy
30,557
+227
+0.7% +$112K 0.09% 178
2022
Q1
$14.9M Buy
30,330
+1,791
+6% +$819K 0.09% 171
2021
Q4
$13.2M Buy
28,539
+2,096
+8% +$882K 0.08% 178
2021
Q3
$9.87M Buy
26,443
+2,503
+10% +$951K 0.07% 228
2021
Q2
$9.14M Buy
23,940
+2,315
+11% +$885K 0.07% 215
2021
Q1
$7.76M Buy
21,625
+3,189
+17% +$1.03M 0.07% 221
2020
Q4
$5.92M Buy
18,436
+9,085
+97% +$2.79M 0.07% 200
2020
Q3
$2.51M Buy
9,351
+522
+6% +$140K 0.04% 321
2020
Q2
$2.32M Buy
8,829
+977
+12% +$261K 0.04% 293
2020
Q1
$1.78M Buy
7,852
+3,997
+104% +$1.09M 0.04% 338
2019
Q4
$1.16M Buy
3,855
+121
+3% +$33.3K 0.02% 484
2019
Q3
$896K Buy
3,734
+227
+6% +$62.2K 0.02% 514
2019
Q2
$990K Sell
3,507
-267
-7% -$72.9K 0.03% 462
2019
Q1
$1.08M Buy
+3,774
New +$1.09M 0.04% 398

Other funds holding ELV

Mercer Global Advisors's ELV Position: Q1 2026 in Review

Mercer Global Advisors reduced its Elevance Health (ELV) stake by 7.9% in Q1 2026, selling an estimated $494K and leaving 17,624 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #748.

Mercer Global Advisors first reported a position in ELV in Q1 2019 and has held it in 26 quarters since. The position peaked at $24.6M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Mercer Global Advisors held 17,624 shares of Elevance Health worth $5.16M as of Q1 2026.
  • Mercer Global Advisors sold 1,503 Elevance Health shares in Q1 2026, an estimated $494K.
  • Elevance Health made up 0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #748 holding.
  • Mercer Global Advisors first reported a position in Elevance Health in Q1 2019 and has held it in 26 quarters since.
  • Mercer Global Advisors's Elevance Health position peaked at $24.6M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.